Similar articles

• Cholesterol, statins, and mortality.

  Law M, Wald N. Law M, et al. Lancet. 2008 Apr 5;371(9619):1161-2; author reply 1162-3. doi: 10.1016/S0140-6736(08)60516-4. Lancet. 2008. PMID: 18395571 No abstract available.
• Cholesterol, statins, and mortality.

  Goldstein MR, Mascitelli L, Pezzetta F. Goldstein MR, et al. Lancet. 2008 Apr 5;371(9619):1161; author reply 1162-3. doi: 10.1016/S0140-6736(08)60514-0. Lancet. 2008. PMID: 18395569 No abstract available.
• Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.

  Uchiyama S, Nakaya N, Mizuno K, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Nakamura H; MEGA Study Group. Uchiyama S, et al. J Neurol Sci. 2009 Sep 15;284(1-2):72-6. doi: 10.1016/j.jns.2009.04.002. Epub 2009 May 6. J Neurol Sci. 2009. PMID: 19423132
• Statins for stroke prevention: disappointment and hope.

  Amarenco P, Tonkin AM. Amarenco P, et al. Circulation. 2004 Jun 15;109(23 Suppl 1):III44-9. doi: 10.1161/01.CIR.0000131518.25959.8F. Circulation. 2004. PMID: 15198966 Review.
• Statins and stroke: evidence for cholesterol-independent effects.

  Di Napoli P, Taccardi AA, Oliver M, De Caterina R. Di Napoli P, et al. Eur Heart J. 2002 Dec;23(24):1908-21. doi: 10.1053/euhj.2002.3236. Eur Heart J. 2002. PMID: 12473253 Review. No abstract available.